Use of serum cystatin C to detect early decline of glomerular filtration rate in type 2 diabetes

Internal Medicine

Volumn 46, Issue 12, 2007, Pages 801-806

  Yang, Yi Sun ^a   Peng, Chiung Huei ^b   Lin, Chih Kuang ^a   Wang, Chi Pin ^a   Huang, Chien Ning ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

Chronic kidney disease; Creatinine; Creatinine clearance; Cystatin C; Glomerular filtration rate; Urinary albumin excretion

Indexed keywords

ALBUMIN; CREATININE; CYSTATIN C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHRONIC KIDNEY DISEASE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC DIET; DIABETIC NEPHROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIET RESTRICTION; EARLY DIAGNOSIS; FEMALE; GLOMERULAR DYSFUNCTION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REFERENCE VALUE; TAIWAN; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; BIOLOGICAL MARKERS; CREATININE; CYSTATINS; DIABETES MELLITUS, TYPE 2; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 34547895859     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.6081     Document Type: Article

References (31)

1. American Association of Diabetes. Standards of medical care in diabetes. Diabetes Care 28: S4-S36, 2005.
2. Tsalamandris C, Allen TJ, Gilbert RE, et al. Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes 43: 649-655, 1994.
3. MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, et al. Normoalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care 27: 195-200, 2004.
4. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351: 1285-1295, 2004.
5. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004.
6. Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 36: 29-34, 2000.
7. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 38: 1933-1953, 1992.
8. Kyhse-Andersen P, Schmidt C, Nordin G, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbimetric method, is better marker than serum creatinine for glomerular filtration rate. Clin Chem 40: 1921-1926, 1994.
9. Nilsson-Ehle P, Grubb A. New markers for the determination of GFR: iohexol clearance and cystatin C serum concentration. Kidney Int 46: S17-S19, 1994.
10. National Kidney Foundation K/DOQI. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S200, 2002.
11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41, 1976.
12. Harmoinen A, Lehtimaki T, Korpela. M, Turjanmaa V, Saba H. Diagnostic accuracies of plasma creatinine, cystatin C and glomerular filtration rate calculated, by the Cockcroft-Gault and Levey (MDRD) formula. Clin Chem 47: 1223-1225, 2003.
13. Grubb A, Simonsen O, Sturfelt G, Truedsson H, Thysell H. Serum concentration of cystatin C, factor D and B2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand 218: 499-503, 1985.
14. Simonsen O, Grubb A, Thysell H. The blood serum concentration of cystatin C as a measure of the glomerular filtration rate. Scand J Clin Lab Invest 45: 97-101, 1985.
15. Nielsen S, Rehling M, Schmitz C, Mogensen CE. Validity of rapid estimation of glomerutar filtration rate in type 2 diabetic patients with normal renal function. Nephrol Dial Transplant 14: 615-649, 1999.
16. Van Den, Noortgate NJ, Janssens VM, Delanghe JR, Afschrift MB, Lameire NH. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old. J Am Geriatr Soc 50: 1278-1282, 2002.
17. Newman DJ, Thakkar H, Edwards RG, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 47: 312-318, 1995.
18. Tomino Y, Suzuki, S, Gohda T, et al. Serum cystatin C may predict the prognostic stages of patients with IgA nephropathy prior to renal biopsy. J Clin Lab Anal 15: 25-29, 2001.
19. Shimizu-Tokiwa A, Kobata M, Io H, et al. Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine. Nephron 92: 224-226, 2002.
20. Piwowar A, Knapik-Kordecka M, Buczynska H, Warwas M. Plasma cystatin C concentration in non-insulin-dependent diabetes mellitus: relation with nephropathy. Arch Immunol Ther Exp 47: 327-331, 1999.
21. Finney H, Newman DJ, Price CP. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 37: 49-59, 2000.
22. Harmoinen AP, Kouri TT, Wirta OR, et al. Evaluation of plasma cystatin C as a marker for glomerular filtration rate inpatients with type 2 diabetes. Clin Nephrol 52: 363-370, 1999.
23. Mussap M, Vestra MD, Fioretto P, et al. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 61: 1453-1461, 2002.
24. Tan GD, Lewis AV, James TJ, Altmann P, Taylor RP, Levy JC. Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type I diabetes. Diabetes Care 25: 2004-2009, 2002.
25. Christensson AG, Grubb AO, Nilsson JA, Norrgren K, Sterner G, Sundkvist G. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy. J Intern Med 256: 510-518, 2004.
26. Shimizu A, Horikoshi S, Rinnno H, Kobata M, Saito K, Tomino Y. Serum cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy. J Clin Lab Anal 17: 164-167, 2003.
27. Bicik Z, Bahcebasi T, Kulaksizoglu S, Yavuz O. The efficacy of cystatin C assay in the prediction of glomerular filtration rate. Is it a more reliable marker for renal failure? Clin Chem Lab Med 43: 855-861, 2005.
28. Oddoze C, Morange S, Portugal H, Berland Y, Dussol B. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes. Am J Kidney Dis 38: 310-316, 2001.
29. American Diabetes Association. Standards of medical care in diabetes (Position Statement). Diabetes Care 29: S4-S42, 2006.
30. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40: 221-226, 2002.
31. Perkins BA, Nelson RG, Ostrander BE, et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration:results of a 4-year follow-up study. J Am Soc Nephrol 16: 1404-1412, 2005.